Capital International Sarl Astrazeneca PLC Transaction History
Capital International Sarl
- $3.71 Billion
- Q3 2024
A detailed history of Capital International Sarl transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International Sarl holds 44,608 shares of AZN stock, worth $2.96 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
44,608
Previous 38,011
17.36%
Holding current value
$2.96 Million
Previous $2.96 Million
17.24%
% of portfolio
0.09%
Previous 0.09%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...